AAAAAA

   
Results: 1-25 | 26-38 |
Results: 26-38/38
EXPERIENCE OF ONCE-DAILY AMINOGLYCOSIDE DOSING USING A TARGET AREA UNDER THE CONCENTRATION-TIME CURVE
Authors: BARCLAY ML DUFFULL SB BEGG EJ BUTTIMORE RC
Citation: Ml. Barclay et al., EXPERIENCE OF ONCE-DAILY AMINOGLYCOSIDE DOSING USING A TARGET AREA UNDER THE CONCENTRATION-TIME CURVE, Australian and New Zealand Journal of Medicine, 25(3), 1995, pp. 230-235
AMINOGLYCOSIDE TOXICITY AND RELATION TO DOSE REGIMEN
Authors: BARCLAY ML BEGG EJ
Citation: Ml. Barclay et Ej. Begg, AMINOGLYCOSIDE TOXICITY AND RELATION TO DOSE REGIMEN, Adverse drug reactions and toxicological reviews, 13(4), 1994, pp. 207-234
VANCOMYCIN TOXICITY - WHAT IT THE EVIDENCE FOR DOSE-DEPENDENCY
Authors: DUFFULL SB BEGG EJ
Citation: Sb. Duffull et Ej. Begg, VANCOMYCIN TOXICITY - WHAT IT THE EVIDENCE FOR DOSE-DEPENDENCY, Adverse drug reactions and toxicological reviews, 13(2), 1994, pp. 103-114
WHAT IS THE EVIDENCE FOR ONCE-DAILY AMINOGLYCOSIDE THERAPY
Authors: BARCLAY ML BEGG EJ HICKLING KG
Citation: Ml. Barclay et al., WHAT IS THE EVIDENCE FOR ONCE-DAILY AMINOGLYCOSIDE THERAPY, Clinical pharmacokinetics, 27(1), 1994, pp. 32-48
THE PHARMACOKINETICS OF QUINAPRIL AND QUINAPRILAT IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: BEGG EJ ROBSON RA IKRAM H RICHARDS AM BAMMERTADAMS JA OLSON SC POSVAR EL REECE PA SEDMAN AJ
Citation: Ej. Begg et al., THE PHARMACOKINETICS OF QUINAPRIL AND QUINAPRILAT IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, British journal of clinical pharmacology, 37(3), 1994, pp. 302-304
EFFICACIES OF DIFFERENT VANCOMYCIN DOSING REGIMENS AGAINST STAPHYLOCOCCUS-AUREUS DETERMINED WITH A DYNAMIC IN-VITRO MODEL
Authors: DUFFULL SB BEGG EJ CHAMBERS ST BARCLAY ML
Citation: Sb. Duffull et al., EFFICACIES OF DIFFERENT VANCOMYCIN DOSING REGIMENS AGAINST STAPHYLOCOCCUS-AUREUS DETERMINED WITH A DYNAMIC IN-VITRO MODEL, Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2480-2482
HOSPITAL DRUG-THERAPY COST-CONTAINMENT THROUGH A PREFERRED MEDICINES LIST AND DRUG UTILIZATION REVIEW SYSTEM
Authors: PEARCE MJ BEGG EJ
Citation: Mj. Pearce et Ej. Begg, HOSPITAL DRUG-THERAPY COST-CONTAINMENT THROUGH A PREFERRED MEDICINES LIST AND DRUG UTILIZATION REVIEW SYSTEM, New Zealand medical journal, 107(974), 1994, pp. 101-104
MANAGEMENT OF RAISED BLOOD-PRESSURE
Authors: NICHOLLS MG BEGG EJ GILCHRIST NL KELLAWAY GSM RICHARDS AM SIMPSON FO
Citation: Mg. Nicholls et al., MANAGEMENT OF RAISED BLOOD-PRESSURE, New Zealand medical journal, 107(970), 1994, pp. 17-17
ONCE-DAILY DOSING OF AMINOGLYCOSIDES - REPLY
Authors: ELLISPEGLER RB CHAMBERS ST BEGG EJ
Citation: Rb. Ellispegler et al., ONCE-DAILY DOSING OF AMINOGLYCOSIDES - REPLY, Australian and New Zealand Journal of Medicine, 24(6), 1994, pp. 731-731
AMINOGLYCOSIDE DOSING - TIME TO CHANGE
Authors: ELLISPEGLER RB CHAMBERS S BEGG EJ BARCLAY ML
Citation: Rb. Ellispegler et al., AMINOGLYCOSIDE DOSING - TIME TO CHANGE, Australian and New Zealand Journal of Medicine, 24(4), 1994, pp. 359-361
MODELING OF THE PASSAGE OF DRUGS INTO MILK
Authors: BEGG EJ ATKINSON HC
Citation: Ej. Begg et Hc. Atkinson, MODELING OF THE PASSAGE OF DRUGS INTO MILK, Pharmacology & therapeutics, 59(3), 1993, pp. 301-310
APPLICATION OF A SIMPLIFIED METHOD TO DETERMINE BIOAVAILABILITY OF ANORAL DOSE OF PHENYTOIN
Authors: DAVIS AL BEGG EJ KENNEDY MC GRAHAM GG
Citation: Al. Davis et al., APPLICATION OF A SIMPLIFIED METHOD TO DETERMINE BIOAVAILABILITY OF ANORAL DOSE OF PHENYTOIN, Journal of pharmacokinetics and biopharmaceutics, 21(2), 1993, pp. 195-208
HOW VANCOMYCIN IS USED IN AUSTRALASIA - A SURVEY
Authors: DUFFULL SB CHAMBERS ST BEGG EJ
Citation: Sb. Duffull et al., HOW VANCOMYCIN IS USED IN AUSTRALASIA - A SURVEY, Australian and New Zealand Journal of Medicine, 23(6), 1993, pp. 662-666
Risultati: 1-25 | 26-38 |